Clinical Research Directory
Browse clinical research sites, groups, and studies.
Heart Failure Biomarkers
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Summary
Systemic inflammation is closely associated with the development and progression of heart failure (HF). The study assessed the fibrin/albumin (FAR) ratio, a very important biomarker, as a prognostic indicator of HE. Study population is composed by patients who were addicted with heart failure diagnosed for the first time or already under treatment (NYHA class II-IV) and reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF).
Official title: Biomarker Assessment in Heart Failure with Reduced Systolic Function (HFrEF) and Preserved Systolic Function (HFpEF)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
114
Start Date
2024-10-30
Completion Date
2025-10-30
Last Updated
2024-09-27
Healthy Volunteers
No
Conditions
Interventions
Data collection
Given the observational nature of the study, the intervention is a simple data collection
Locations (2)
IRCCS Ospedale Galeazzi-Sant'Ambrogio
Milan, Italy, Italy
IRCCS Galeazzi-Sant'Ambrogio
Milan, Italy